hospit
estim
million
hospit
day
cost
billion
annual
cost
relat
influenza
epidem
surpass
billion
caus
million
lost
work
hour
year
time
diagnosi
influenza
earli
recognit
influenza
outbreak
epidem
key
compon
prevent
influenzarel
complic
hospit
death
primari
gateway
health
care
system
emerg
depart
ed
frequent
point
entri
patient
influenza
seek
medic
attent
result
emerg
physician
well
posit
play
pivot
role
promptli
identifi
adequ
manag
influenza
commun
outbreak
epidem
articl
provid
updat
overview
influenza
enhanc
clinic
judgment
emerg
physician
facilit
accur
decis
make
diagnosi
season
influenza
therebi
minim
influenza
potenti
morbid
mortal
epidemiolog
influenza
differ
global
influenza
outbreak
occur
specif
season
refer
season
influenza
influenza
activ
present
throughout
year
northern
southern
hemispher
temper
zone
influenza
highli
season
attack
predominantli
occur
winter
month
northern
hemispher
countri
like
unit
state
canada
season
influenza
usual
start
novemb
peak
decemb
march
abat
may
wherea
southern
hemispher
countri
like
australia
flu
start
may
peak
june
septemb
end
novemb
substanti
fluctuat
influenza
viral
transmiss
pattern
may
occur
peak
occur
much
earlier
later
anticip
contrast
tropic
region
lack
distinct
winter
season
exhibit
differ
pattern
activ
influenza
virus
may
isol
year
round
biannual
influenza
outbreak
typic
outbreak
usual
begin
suddenli
spread
commun
peak
period
week
continu
averag
durat
month
term
clinic
sign
import
emerg
physician
first
indic
onset
flu
outbreak
commun
surg
pediatr
febril
respiratori
ill
follow
increas
adult
influenzalik
ill
ili
predomin
front
line
health
care
system
ed
includ
emerg
physician
well
posit
detect
local
outbreak
flu
earli
stage
notifi
appropri
public
health
author
take
proper
measur
contain
outbreak
similarli
emerg
physician
play
pivot
role
contain
emerg
flu
pandem
keep
abreast
global
influenza
epidem
influenza
virus
belong
orthomyxovirida
class
virus
structur
consist
inner
core
outer
membran
core
contain
nucleoprotein
antigen
determin
classif
influenza
viru
basic
type
b
c
outer
membran
contain
coat
protein
includ
glycoprotein
influenza
virus
categor
base
immunolog
import
glycoprotein
hemagglutinin
h
differ
subtyp
neuraminidas
n
differ
subtyp
instanc
influenza
viru
respons
flu
pandem
express
hemagglutinin
neuraminidas
subtyp
wherea
influenza
viru
caus
influenza
pandem
express
hemagglutinin
neuraminidas
subtyp
influenza
b
c
virus
subcategor
influenza
b
c
virus
similar
structur
biolog
characterist
differ
antigen
vari
preval
virul
influenza
preval
frequent
caus
season
outbreak
epidem
human
infect
subtyp
lead
sever
morbid
influenza
b
c
addit
influenza
subtyp
caus
pandem
influenza
current
predomin
viru
subtyp
caus
influenza
infect
human
sinc
flu
virus
circul
caus
season
influenza
worldwid
wherea
influenza
subtyp
circul
human
sinc
influenza
b
virus
circul
less
wide
influenza
caus
fewer
season
outbreak
epidem
wherea
influenza
c
virus
caus
sporad
case
minor
outbreak
epidem
case
human
develop
antibodi
influenza
virus
childhood
provid
protect
later
sever
diseas
howev
children
less
year
age
yet
acquir
antibodi
influenza
c
viru
caus
seriou
respiratori
infect
antigen
drift
antigen
shift
influenza
virus
influenza
b
c
virus
natur
tendenc
period
undergo
hemagglutinin
neuraminidas
antigen
chang
small
point
mutat
rna
gene
segment
code
glycoprotein
lead
minor
hemagglutinin
neuraminidas
antigen
chang
call
antigen
drift
result
local
outbreak
larg
mutat
viral
gene
reassort
result
major
hemagglutinin
neuraminidas
antigen
chang
refer
antigen
shift
associ
widespread
epidem
pandem
influenza
greater
propens
antigen
variat
influenza
viru
type
abl
undergo
antigen
shift
wherea
viru
type
influenza
b
c
abil
undergo
antigen
drift
influenza
viral
infect
start
transfer
virusladen
respiratori
secret
infect
person
immunolog
suscept
host
viru
initi
attach
epitheli
cell
upper
respiratori
tract
neutral
host
immun
system
viru
continu
invad
cell
viru
descend
respiratori
tract
adsorpt
bind
viral
hemagglutinin
host
cell
sialic
acidconjug
glycoprotein
viru
enter
host
cell
adsorpt
bind
deem
necessari
viru
cell
entri
epidemiolog
signific
configur
sialic
acidconjug
glycoprotein
differ
one
speci
anoth
may
exert
crucial
role
limit
transfer
influenza
virus
across
speci
viru
enter
host
cell
immedi
disrupt
normal
cell
function
start
replic
releas
viral
progeni
neuraminidas
essenti
viral
releas
propag
viral
replic
lead
host
cell
degrad
death
via
sever
mechan
shut
protein
synthesi
releas
potent
cytokin
cytokin
type
interferon
interleukin
tumor
necrosi
factor
well
inflammatori
mediat
thought
caus
cough
system
symptom
flu
viru
replic
start
within
hour
host
cell
infect
continu
hour
symptom
onset
durat
incub
period
symptom
onset
viru
shed
rang
hour
depend
part
inoculum
dose
quantiti
shed
viru
measur
specimen
exhibit
distinct
pattern
tempor
correl
symptom
onset
sever
ill
viru
shed
observ
start
within
hour
onset
symptom
peak
day
onset
symptom
develop
remain
high
anoth
day
correl
ill
sever
rapidli
declin
come
end
approxim
day
infect
howev
certain
circumst
viru
shed
continu
week
two
key
factor
influenc
durat
viral
shed
age
sever
ill
young
children
rel
lack
immun
shed
viru
day
patient
chronic
diseas
sever
complic
influenza
shed
viru
averag
day
longer
uncompl
influenza
elderli
immunocompromis
patient
viral
shed
potenti
infect
persist
week
even
month
multipl
patholog
chang
pulmonari
function
abnorm
observ
activ
uncompl
acut
influenza
infect
bronchoscopi
often
show
inflamm
edema
bronchial
mucosa
notabl
lower
respiratori
tract
lead
decreas
forc
flow
rate
increas
pulmonari
resist
may
persist
week
clinic
recoveri
patient
asthma
chronic
obstruct
pulmonari
diseas
influenza
caus
acut
decreas
forc
expiratori
vital
capac
fvc
forc
expiratori
volum
second
viru
infect
advanc
lung
parenchyma
either
via
inhal
contigu
spread
upper
respiratori
tract
caus
primari
viral
pneumonia
tracheiti
bronchiti
bronchiol
seen
character
submucos
hyperemia
edema
focal
hemorrhag
bloodi
fluid
loss
normal
ciliat
epithelium
disrupt
normal
epitheli
barrier
infect
abnorm
ciliari
clearanc
mechan
along
increas
adher
bacteria
virusinfect
epitheli
cell
predispos
bacteri
superinfect
common
pathogen
respons
bacteri
infect
staphylococcu
aureu
streptococcu
pneumonia
haemophilu
influenza
sign
symptom
season
influenza
variabl
sever
depend
age
patient
adult
influenza
usual
character
respiratori
symptom
constitut
symptom
fever
myalgia
malais
headach
abrupt
onset
common
patient
often
abl
report
time
onset
respiratori
symptom
cough
may
initi
mild
progress
caus
dyspnea
pleurit
chest
pain
degre
fever
variabl
fever
elderli
usual
sever
young
patient
flu
season
patient
influenzalik
symptom
proven
influenza
infect
like
cough
vs
fever
vs
cough
fever
togeth
vs
andor
nasal
congest
vs
compar
without
influenza
decreas
likelihood
influenza
absenc
fever
likelihood
ratio
lr
confid
interv
ci
cough
lr
ci
nasal
congest
lr
ci
find
summari
lr
less
patient
may
also
present
isol
gastrointestin
central
nervou
system
cn
involv
children
influenza
often
present
classic
symptom
often
describ
symptom
tend
gastrointestin
symptom
symptom
mimic
bacteri
sepsi
high
fever
children
influenza
may
present
febril
seizur
uncompl
influenza
physic
find
may
evid
hyperemia
pharynx
even
sever
sore
throat
complaint
mild
cervic
lymphadenopathi
otiti
media
may
present
especi
younger
patient
dri
cough
usual
note
chest
examin
clear
lung
rhonchi
unless
complic
pneumonia
complic
fever
bodi
ach
last
day
cough
lack
energi
may
last
week
pneumonia
major
complic
influenza
occur
especi
highrisk
patient
children
age
less
year
especi
age
year
adult
age
year
person
chronic
diseas
person
immunosuppress
women
pregnant
postpartum
within
week
deliveri
person
age
year
younger
receiv
longterm
aspirin
therapi
first
nationsalaska
nativ
person
morbidli
obes
ie
bodi
mass
index
bmi
greater
equal
resid
nurs
home
chroniccar
facil
pneumonia
either
viral
secondari
bacteri
caus
primari
viral
pneumonia
uncommon
tend
increas
symptom
sever
howev
influenza
outbreak
influenza
viru
type
b
respons
half
communityacquir
viral
pneumonia
case
secondari
bacteri
pneumonia
signific
complic
influenza
account
influenza
death
children
hospit
influenzaassoci
pneumonia
higher
risk
intens
care
admiss
respiratori
failur
death
compar
hospit
influenza
without
pneumonia
classic
influenza
patient
complic
pneumonia
exacerb
fever
respiratori
symptom
initi
improv
common
bacterium
pneumonia
account
approxim
case
staphylococcu
aureu
haemophilu
influenza
also
import
common
organ
influenza
season
case
communityacquir
aureu
pneumonia
report
cdc
almost
case
anteced
concomit
viral
ill
aureu
cultur
mrsa
median
age
year
known
pertin
medic
histori
approxim
half
patient
final
disposit
known
die
median
day
symptom
onset
despit
select
bia
case
report
communityassoci
aureu
camrsa
influenza
emerg
depart
pneumonia
account
sever
pneumonia
high
mortal
young
otherwis
healthi
patient
influenza
therefor
empir
therapi
sever
communityacquir
pneumonia
includ
treatment
aureu
includ
mrsa
neurolog
complic
includ
enceph
transvers
myeliti
syndrom
rey
syndrom
report
patient
use
aspirin
influenza
infect
myositi
rare
report
commonli
children
adult
present
earli
convalesc
acut
onset
pain
tender
lower
leg
muscl
sever
enough
limit
walk
serum
creatin
kinas
ck
level
transient
increas
complet
recoveri
gener
occur
day
renal
failur
rare
cardiovascular
involv
occur
directli
affect
myocardium
exacerb
exist
cardiovascular
condit
frequenc
myocardi
involv
influenza
infect
variabl
rate
report
literatur
although
depend
method
use
detect
myocardi
involv
although
mani
patient
asymptomat
signific
proport
electrocardiogram
chang
fulmin
myocard
result
cardiogen
shock
death
may
occur
patient
condit
deterior
hemodynam
compromis
cardiac
involv
consid
mainstay
treatment
influenza
myocard
support
cardiovascular
death
also
increas
influenza
epidem
increas
death
coronari
arteri
diseas
death
shown
reduc
influenza
vaccin
offer
patient
cardiovascular
diseas
rare
complic
encount
includ
toxic
shock
syndrom
conjunct
secondari
aureu
infect
parot
influenza
difficult
diagnos
base
clinic
symptom
alon
initi
symptom
influenza
similar
caus
infecti
agent
includ
mycoplasma
pneumonia
adenoviru
respiratori
syncyti
viru
rhinoviru
parainfluenza
virus
legionella
import
ed
develop
clinic
pathway
identifi
ili
contagi
patient
segreg
treat
effect
cdc
defin
ili
patient
temperatur
greater
c
f
plu
either
cough
sore
throat
absenc
known
caus
influenza
describ
patient
influenza
may
atyp
present
fever
alway
present
especi
prematur
infant
young
infant
elderli
patient
immunosuppress
patient
patient
may
present
myalgia
headach
fatigu
complic
ed
need
consid
variabl
clinic
present
preval
influenza
commun
regard
investig
treatment
infect
control
isol
protocol
patient
suspect
influenza
standard
laboratori
investig
complet
blood
count
electrolyt
result
usual
nonspecif
leukopenia
typic
thrombocytopenia
may
present
patient
physic
sign
suggest
mening
undergo
lumbar
punctur
patient
hypoxemia
elderli
highrisk
patient
pulmonari
symptom
chest
radiograph
perform
exclud
pneumonia
dyspnea
chest
pain
typic
use
indic
obtain
chest
radiograph
short
breath
may
use
indic
pneumoniacompl
influenza
radiolog
find
includ
bilater
interstiti
infiltr
focal
infiltr
may
indic
superimpos
bacteri
pneumonia
diagnost
test
perform
everi
patient
present
ed
ili
especi
circul
influenza
outbreak
epidem
confirm
influenza
viru
infect
requir
clinic
decis
prescrib
antivir
medic
decis
administ
influenza
treatment
chemoprophylaxi
base
clinic
ill
epidemiolog
factor
start
therapi
delay
pend
result
especi
influenza
outbreak
influenza
diagnost
test
clinic
indic
test
result
alter
patient
clinic
care
influenc
clinic
practic
patient
fig
posit
influenza
test
may
use
confirm
influenza
viru
commun
may
affect
clinic
practic
relat
home
care
guidanc
hospit
infect
control
practic
futur
test
practic
forth
neither
rapid
influenza
test
clinic
predict
rule
superior
clinic
judgment
alon
diagnosi
influenza
one
studi
patient
confirm
influenza
overal
clinic
judgment
sensit
ci
specif
ci
improv
sensit
ci
specif
ci
patient
present
within
hour
rapid
influenza
test
sensit
ci
specif
ci
clinic
predict
rule
show
sensit
ci
specif
ci
thu
time
high
diseas
preval
influenza
outbreak
epidem
patient
exhibit
ili
symptom
diagnos
clinic
influenza
without
perform
diagnost
test
clinician
consult
cdc
global
flu
activ
updat
http
wwwcdcgovflu
internationalactivityhtm
latest
updat
intern
flu
situat
fluview
http
wwwcdcgovfluweekli
summari
flu
activ
unit
state
diagnost
test
ideal
indic
circumst
sporad
case
ili
period
low
diseas
preval
sever
ill
patient
influenza
confirm
sporad
case
ili
rule
anoth
viral
diagnosi
exampl
sever
acut
respiratori
syndrom
sar
coronaviru
diagnost
test
recommend
sever
ill
patient
greater
urgenc
make
correct
diagnosi
provid
appropri
medic
manag
case
rapid
influenza
diagnost
test
ridt
revers
transcriptas
polymeras
chain
reaction
rtpcr
appropri
evidencebas
clinic
practic
guidelin
diagnosi
manag
chemoprophylaxi
season
influenza
develop
infecti
diseas
societi
america
recommend
follow
patient
popul
undergo
diagnost
test
influenza
test
result
influenc
medic
manag
box
influenza
viru
isol
differ
type
specimen
includ
nasal
throat
nasopharyng
swab
aspir
wash
sputum
sampl
nasopharyng
specimen
swab
aspir
sensit
detect
viru
throat
swab
sputum
specimen
one
comparison
rapid
assay
immunofluoresc
influenza
detect
sensit
method
increas
approxim
nasopharyng
swab
instead
throat
swab
use
accept
specimen
also
vari
depend
specif
diagnost
test
tabl
optim
time
frame
collect
diagnost
specimen
influenza
emerg
depart
confirm
influenza
viru
infect
diagnost
test
requir
clinic
decis
prescrib
antivir
medic
decis
administ
antivir
medic
influenza
treatment
chemoprophylaxi
indic
base
upon
clinic
ill
epidemiolog
factor
start
therapi
delay
pend
test
result
http
wwwcdcgovfluprofessionalsdiagnosisclinicianguidanceridthtm
respiratori
specimen
collect
ill
patient
earli
possibl
onset
symptom
ideal
hour
onset
help
maxim
influenza
test
sensit
influenza
likeil
histori
feverish
document
fever
either
cough
sore
throat
fever
respiratori
symptom
etc
note
person
may
atyp
present
eg
elderli
young
infant
immunosuppress
patient
certain
chronic
medic
condit
fever
alway
present
eg
prematur
infant
young
infant
elderli
immunosuppress
symptom
associ
influenza
includ
myalgia
headach
fatigu
complic
includ
exacerb
underli
chronic
diseas
eg
congest
cardiac
failur
asthma
pneumonia
bacteri
coinfect
bronchiol
croup
encephalopathi
seizur
myositi
other
eg
decis
use
antibiot
antivir
medic
conduct
diagnost
test
recommend
home
care
recommend
ill
person
live
person
highrisk
condit
consult
infecti
diseas
societi
america
american
thorac
societi
associ
american
physician
advisori
committe
immun
practic
antibiot
guidanc
person
year
year
pregnant
women
person
chronic
lung
diseas
includ
asthma
heart
diseas
renal
metabol
hematolog
neurolog
diseas
immunosuppress
morbid
obes
larg
depend
amount
viral
shed
time
test
immunocompet
children
adult
viral
shed
brief
specimen
sampl
yield
best
result
first
day
ill
low
viral
titer
first
hour
follow
onset
clinic
ill
suggest
caus
falseneg
result
patient
test
earli
similarli
specimen
obtain
day
ill
increas
likelihood
falseneg
result
decreas
viru
shed
immunocompet
infant
young
children
spread
viru
longer
week
ideal
permit
collect
specimen
day
ill
irrespect
age
specimen
collect
immunocompromis
person
also
exceed
day
ill
viru
shed
patient
popul
last
week
even
month
ed
collect
serum
specimen
recommend
diagnost
purpos
result
readili
avail
therefor
guid
clinic
decis
make
manag
influenza
season
test
done
follow
person
result
influenc
clinic
manag
outpati
immunocompet
person
age
high
risk
develop
influenza
complic
eg
hospit
death
present
acut
febril
respiratori
symptom
day
less
ill
onset
viru
usual
shed
outpati
immunocompromis
person
age
present
febril
respiratori
symptom
irrespect
time
sinc
ill
onset
immunocompromis
person
shed
influenza
virus
week
month
hospit
person
age
immunocompet
immunocompromis
fever
respiratori
symptom
includ
diagnosi
communityacquir
pneumonia
irrespect
time
sinc
ill
onset
elderli
person
infant
present
suspect
sepsi
fever
unknown
origin
irrespect
time
sinc
ill
onset
children
fever
respiratori
symptom
present
medic
evalu
irrespect
time
sinc
ill
onset
person
age
develop
fever
respiratori
symptom
hospit
admiss
irrespect
time
sinc
ill
onset
immunocompet
person
acut
febril
respiratori
symptom
high
risk
develop
complic
secondari
influenza
infect
may
test
purpos
obtain
local
surveil
data
throughout
year
test
done
follow
person
health
care
personnel
resid
visitor
institut
experienc
influenza
outbreak
present
febril
respiratori
symptom
within
day
ill
onset
person
epidemiolog
link
influenza
outbreak
eg
household
close
contact
person
suspect
influenza
return
travel
countri
influenza
virus
may
circul
particip
intern
mass
gather
cruis
ship
passeng
present
within
day
ill
onset
tabl
b
serolog
test
recommend
routin
patient
diagnosi
c
fourfold
greater
increas
antibodi
titer
acut
collect
within
first
week
ill
convalesc
phase
collect
week
acut
sampl
indic
recent
infect
data
ref
sever
differ
laboratori
test
method
detect
influenza
viru
avail
unit
state
tabl
canada
tabl
method
includ
immunofluoresc
microscopi
direct
indirect
antibodi
stain
viral
cultur
convent
rapid
rtpcr
ridt
serolog
test
among
test
method
ridt
rapid
process
yield
time
result
influenc
clinic
decis
make
patient
manag
pertin
need
ed
base
type
influenza
viru
andor
b
detect
diagnost
test
categor
type
detect
influenza
detect
either
influenza
b
discrimin
two
test
detect
distinguish
influenza
b
virus
rtpcr
viral
cultur
identifi
influenza
strain
ridt
rapid
antigen
pointofcar
test
capabl
identifi
influenza
b
viral
type
respiratori
specimen
approxim
minut
ridt
immunoassay
come
userfriendli
diagnost
kit
vari
complex
either
detect
influenza
viru
detect
distinguish
influenza
b
virus
detect
distinguish
influenza
b
virus
commerci
ridt
current
avail
unit
state
canada
list
tabl
gener
ridt
characterist
includ
advantag
disadvantag
describ
box
ridt
valuabl
ed
produc
result
time
clinic
relev
manner
facilit
onsit
pointofcar
diagnosi
influenza
accord
limit
research
led
decreas
demand
diagnost
test
eg
chest
radiographi
blood
cultur
use
antibiot
thu
result
decreas
patient
cost
recommend
use
ridt
develop
promulg
world
health
organ
box
cdc
recent
issu
guidelin
clinician
use
ridt
influenza
season
major
drawback
ridt
limit
reliabl
accur
detect
influenza
viru
depend
wide
varieti
factor
includ
ridt
sensit
specif
posit
neg
predict
valu
type
specimen
collect
time
collect
respect
onset
symptom
although
ridt
exhibit
high
specif
rang
ridt
substanti
lower
sensit
rang
children
decreas
even
approxim
lower
adult
compar
viral
cultur
rtpcr
thu
ridt
diagnost
assay
use
center
posit
result
trust
neg
result
reliabl
exclud
diseas
tabl
display
specif
select
commerci
avail
ridt
correspond
test
sensit
specif
posit
neg
predict
valu
also
vari
accord
studi
time
specimen
collect
also
influenc
accuraci
ridt
result
closer
within
period
viral
shed
ill
specimen
sampl
obtain
accur
result
effort
minim
fals
interpret
ridt
cdc
publish
follow
guidanc
statement
emerg
physician
health
care
profession
must
keep
mind
perform
interpret
ridt
reliabl
posit
ridt
result
increas
patient
clinic
sign
symptom
consist
influenza
collect
specimen
within
hour
ill
onset
increas
likelihood
produc
posit
ridt
result
use
ridt
high
sensit
specif
see
tabl
ridt
sensit
gener
low
moder
rang
approxim
compar
gold
standard
viral
cultur
rtpcr
ridt
low
sensit
yield
falseneg
result
b
ridt
specif
gener
high
approxim
compar
gold
standard
viral
cultur
rtpcr
ridt
high
specif
yield
falseposit
rtpcr
replac
viral
cultur
refer
standard
current
sensit
specif
versatil
diagnost
test
avail
diagnos
influenza
base
nucleic
acid
amplif
rtpcr
detect
influenza
viru
also
differenti
viru
type
subtyp
even
determin
viral
strain
approxim
hour
result
rtpcr
becom
recommend
test
choic
accur
diagnos
influenza
time
fashion
recent
pandem
cdc
releas
method
rtpcr
detect
influenza
allow
clinic
refer
laboratori
standard
methodolog
thu
produc
data
could
compar
laboratori
howev
major
advantag
rtpcr
lie
abil
readili
detect
influenza
virus
peopl
chronic
lung
diseas
immunosuppress
person
may
exhibit
lower
level
viru
suscept
patient
rtpcr
effici
accur
confirm
diagnosi
influenza
support
therapeut
infect
control
decis
immunofluoresc
yield
time
result
within
hour
use
screen
test
howev
immunofluoresc
sever
disadvantag
includ
lower
sensit
specif
compar
viral
cultur
labor
intens
requir
special
train
laboratori
personnel
may
avail
even
larg
hospit
addit
test
perform
depend
adequ
specimen
sampl
must
includ
respiratori
epithelium
cell
influenza
viru
cultur
either
isol
viru
cell
cultur
convent
tube
cultur
provid
result
day
shell
vial
cultur
offer
advantag
faster
turnaround
time
hour
lengthi
turnaround
time
either
method
viral
cultur
use
diagnost
test
ed
aid
initi
clinic
decis
make
manag
howev
viral
cultur
allow
subsequ
analys
includ
sensit
test
subtyp
perform
refer
laboratori
influenza
season
viral
cultur
indic
primarili
confirm
neg
ridt
immunofluoresc
result
well
influenza
viru
surveil
provid
key
inform
regard
influenza
viru
strain
subtyp
offseason
viral
cultur
indic
patient
present
ed
within
day
symptom
onset
suspect
ili
especi
person
epidemiolog
link
influenza
outbreak
serolog
test
use
recommend
ed
result
readili
avail
therefor
facilit
clinic
judgment
diagnosi
manag
influenza
serolog
test
includ
hemagglutinin
inhibit
neutral
complementfix
enzymelink
immunosorb
assay
elisa
mainli
use
establish
diagnosi
retrospect
research
purpos
individu
previous
infect
influenza
virus
reliabl
determin
antibodi
titer
singl
serum
sampl
collect
ed
inadequ
pair
specimen
sampl
acut
convalesc
sera
need
whenev
interpret
influenza
diagnost
test
emerg
physician
health
care
profession
must
keep
mind
limit
test
especi
ridt
addit
clinician
awar
diseas
preval
commun
given
time
level
influenza
activ
known
affect
accuraci
reliabl
test
result
respect
patient
manag
posit
influenza
test
result
necessarili
rule
overli
coinfect
addit
pathogen
case
initi
neg
influenza
test
result
less
sensit
diagnost
method
like
ridt
clinician
contempl
addit
diagnost
test
rtpcr
cultur
decid
whether
antivir
treatment
initi
empir
current
antivir
medic
drug
class
approv
avail
treatment
prevent
influenza
unit
state
canada
countri
medic
includ
amantadin
rimantadin
belong
drug
class
adamantan
oseltamivir
tamiflu
roch
zanamivir
relenza
glaxosmithklin
belong
class
neuraminidas
na
inhibitor
adamantan
activ
influenza
viru
wherea
na
inhibitor
activ
influenza
b
virus
antivir
pharmacolog
properti
compar
tabl
last
sever
year
adamantin
becom
less
clinic
use
widespread
resist
influenza
viru
strain
result
amantadin
rimantadin
current
recommend
treatment
chemoprophylaxi
influenza
viru
goal
influenza
pharmacotherapi
decreas
symptom
prevent
associ
complic
reduc
function
disabl
hospit
mortal
treatment
decis
administ
antivir
therapi
take
account
factor
time
sinc
symptom
onset
underli
condit
sever
diseas
abbrevi
crcl
creatinin
clearanc
fda
us
food
drug
administr
gi
gastrointestin
fda
author
treatment
soiv
oseltamivir
children
greater
equal
month
age
b
fda
author
prophylaxi
soiv
oseltamivir
children
greater
equal
year
age
accord
cdc
publish
guidelin
antivir
treatment
recommend
patient
infect
influenza
viru
meet
follow
criteria
patient
laboratoryconfirm
highli
suspect
influenza
viru
infect
consid
high
risk
develop
influenza
complic
box
treatment
recommend
irrespect
ill
sever
vaccin
statu
patient
laboratoryconfirm
highli
suspect
influenza
viru
infect
requir
hospit
irrespect
underli
ill
vaccin
statu
patient
laboratoryconfirm
highli
suspect
influenza
viru
infect
sever
complic
progress
ill
antivir
treatment
consid
adult
children
influenza
viru
infect
meet
follow
criteria
outpati
high
risk
complic
see
box
ill
improv
posit
influenza
test
result
specimen
obtain
hour
onset
symptom
outpati
laboratoryconfirm
highli
suspect
influenza
viru
infect
increas
risk
complic
whose
onset
symptom
less
hour
ed
present
would
like
shorten
durat
ill
reduc
risk
complic
outpati
laboratoryconfirm
highli
suspect
influenza
viru
infect
close
contact
person
high
risk
complic
secondari
influenza
infect
patient
whose
onset
symptom
occur
hour
ed
present
persist
moder
sever
ill
may
also
benefit
treatment
viral
titer
rapidli
decreas
day
ill
untreat
previous
healthi
person
efficaci
antivir
therapi
directli
relat
time
treatment
initi
studi
found
earli
treatment
especi
initi
within
first
hour
symptom
onset
provid
greatest
benefit
reduc
symptom
antivir
treatment
initi
within
hour
onset
influenza
ill
lead
shorter
durat
symptom
decreas
ill
sever
studi
administ
na
inhibitor
antivir
medic
previous
healthi
patient
uncompl
influenza
result
shorter
durat
ill
day
addit
research
shown
earli
initi
treatment
antivir
also
decreas
rate
seriou
influenzarel
complic
eg
pneumonia
respiratori
failur
death
high
risk
patient
contrast
slight
benefit
observ
healthi
peopl
antivir
treatment
start
hour
onset
uncompl
influenza
result
influenza
antivir
treatment
clinic
indic
initi
time
fashion
prefer
within
hour
symptom
onset
laboratori
confirm
influenza
certain
patient
popul
antivir
treatment
may
still
benefici
even
given
hour
symptom
onset
patient
includ
pregnant
women
patient
sever
progress
ill
requir
hospit
patient
high
risk
suffer
influenza
complic
studi
siston
colleagu
found
pregnant
women
treatment
antivir
medic
decreas
respiratori
complic
death
even
initi
day
symptom
onset
compar
day
base
observ
studi
oseltamivir
decreas
sever
clinic
outcom
hospit
patient
influenza
multivari
influenza
emerg
depart
analysi
treatment
oseltamivir
led
significantli
decreas
risk
death
within
day
hospit
odd
ratio
ci
benefit
detect
even
patient
whose
treatment
initi
hour
onset
symptom
studi
lee
colleagu
found
among
hospit
patient
median
age
year
laboratoryconfirm
influenza
receiv
oseltamivir
benefit
observ
even
oseltamivir
start
hour
ill
onset
influenza
viru
vulner
antivir
drug
continu
evolv
result
emerg
physician
need
familiar
recent
updat
inform
avail
antivir
resist
recommend
antivir
use
januari
cdc
recommend
follow
antivir
drug
treatment
chemoprophylaxi
season
influenza
tabl
effect
way
prevent
control
season
influenza
immun
health
care
worker
patient
procedur
institution
ensur
patient
visitor
respiratori
infect
symptom
follow
triag
procedur
ed
effect
isol
rapidli
possibl
hospit
entranc
ed
triag
clear
signag
instruct
regard
respiratori
hygien
cough
etiquett
face
mask
avail
cover
nose
mouth
cough
sneez
wast
receptacl
need
dispos
contamin
tissu
also
instruct
perform
hand
hygien
passiv
signag
ask
patient
selfidentifi
triag
health
care
team
activ
ask
patient
possibl
symptom
maintain
distanc
least
wait
time
minim
close
monitor
staf
adjust
made
accordingli
period
increas
influenza
activ
facil
consid
set
pretriag
station
facilit
rapid
screen
patient
symptom
influenza
separ
patient
other
registr
identifi
chart
patient
potenti
influenza
expedit
care
wait
room
segreg
area
patient
without
respiratori
symptom
possibl
physic
barrier
separ
patient
ed
patient
evalu
singl
treatment
area
health
care
worker
use
person
protect
equip
ppe
includ
surgic
mask
faceshield
mask
visor
attach
high
chanc
splash
spray
respiratori
secret
glove
longsleev
gown
worn
enter
room
patient
suspect
confirm
influenza
health
care
worker
remov
ppe
leav
patient
room
discard
handsfre
wast
linen
receptacl
within
room
hand
hygien
perform
remov
glove
gown
remov
mask
protect
leav
room
patient
droplet
precaut
ed
need
move
investig
patient
wear
face
mask
continu
follow
cough
etiquett
hand
hygien
appropri
commun
personnel
patient
suspect
confirm
influenza
transfer
depart
eg
radiolog
admit
unit
facil
procedur
perform
patient
suspect
confirm
influenza
infect
may
like
gener
higher
concentr
infecti
respiratori
aerosol
procedur
includ
intub
relat
procedur
eg
manual
ventil
open
endotrach
suction
cardiopulmonari
resuscit
sputum
induct
nebul
therapi
noninvas
posit
pressur
ventil
continu
posit
airway
pressur
cpap
biphas
posit
airway
pressur
bipap
although
limit
data
avail
influenza
transmiss
relat
aerosol
mani
author
recommend
addit
precaut
use
procedur
perform
number
health
care
worker
present
limit
essenti
patient
care
support
present
receiv
influenza
vaccin
low
threshold
intub
rather
use
prolong
aerosolgener
procedur
bipap
cpap
health
care
worker
wear
respiratori
protect
includ
fit
respir
aerosolgener
procedur
respir
use
context
comprehens
respiratori
protect
program
includ
fit
test
train
requir
respiratori
protect
standard
cfr
occup
safeti
health
administr
ohsa
procedur
conduct
airborn
infect
isol
room
aiir
feasibl
aiir
reduc
concentr
infecti
aerosol
prevent
spread
adjac
area
use
control
air
exchang
direct
airflow
aiir
negativepressur
room
rel
surround
area
minimum
air
exchang
per
hour
air
exhaust
directli
outsid
filter
higheffici
particul
air
hepa
filter
recircul
environment
surfac
clean
follow
procedur
visitor
present
aerosolgener
procedur
visit
patient
suspect
confirm
influenza
control
visitor
instruct
limit
movement
within
facil
facil
provid
instruct
visitor
enter
patient
room
hand
hygien
limit
surfac
touch
use
ppe
visitor
advis
contact
health
care
provid
inform
influenza
vaccin
receiv
highrisk
patient
describ
earlier
chemoprophylaxi
may
offer
close
contact
patient
health
care
worker
ed
presum
receiv
educ
train
program
prevent
transmiss
infecti
agent
includ
influenza
program
updat
period
compet
document
health
care
worker
develop
fever
respiratori
symptom
instruct
report
work
work
put
face
mask
promptli
notifi
supervisor
andor
infect
control
personnel
health
care
worker
exclud
work
least
hour
longer
fever
ongo
respiratori
symptom
evalu
determin
appropri
contact
patient
health
care
worker
care
immunocompromis
patient
consid
temporari
assign
exclus
work
day
symptom
onset
resolut
symptom
whichev
longer
administr
antivir
treatment
chemoprophylaxi
health
care
worker
consid
appropri
earli
treatment
antivir
agent
vaccin
especi
import
health
care
worker
higher
risk
influenza
complic
includ
pregnant
women
women
week
give
birth
person
year
older
person
chronic
diseas
asthma
heart
diseas
diabet
diseas
suppress
immun
system
morbid
obes
work
reassign
consid
higher
risk
avoid
potenti
highrisk
exposur
perform
assist
aerosolgener
procedur
patient
suspect
confirm
influenza
ed
adequ
isol
facil
clear
protocol
rapid
admiss
ward
prevent
board
lastli
discharg
instruct
develop
given
everi
patient
influenza
discharg
home
ed
emerg
depart
team
feel
season
flu
influenza
symptom
mild
enough
send
home
observ
recoveri
ill
influenza
contagi
use
proper
precaut
pass
infect
other
leav
emerg
depart
pleas
wear
mask
keep
arriv
home
keep
distanc
other
may
also
wear
home
necessari
use
public
transport
bu
subway
go
home
go
straight
home
make
stop
way
eg
drug
store
groceri
store
given
prescript
make
arrang
famili
member
friend
pick
isol
home
day
onset
ill
least
hour
symptom
resolv
whichev
longer
go
work
school
public
place
share
person
item
towel
drink
cup
cutleri
thermomet
toothbrush
alway
use
hygien
prevent
measur
avoid
contamin
wash
hand
frequent
cough
sneez
crook
elbow
rather
hand
use
tissu
dispos
wast
basket
keep
surround
clean
home
import
monitor
health
sure
ill
worsen
consult
doctor
return
emerg
depart
develop
one
symptom
short
breath
difficulti
breath
chest
pain
recurr
vomit
high
fever
c
f
pay
attent
onset
ill
stay
home
mild
flulik
symptom
occur
go
doctor
fever
c
f
belong
group
risk
develop
influenza
complic
children
less
year
age
pregnant
women
person
year
old
older
person
chronic
diseas
asthma
heart
diseas
diabet
diseas
suppress
immun
system
go
doctor
fever
c
f
one
symptom
chest
pain
child
quiet
less
activ
normal
refus
play
agit
symptom
influenza
pandem
similar
season
flu
ie
fever
headach
myalgia
coryza
gastrointestin
symptom
sore
throat
cough
last
centuri
influenza
pandem
caus
novel
influenza
virus
signific
socal
spanish
flu
kill
million
peopl
worldwid
emerg
novel
viru
genet
combin
human
swine
influenza
virus
mani
person
littl
immun
new
pandem
viru
diseas
spread
quickli
pandem
rate
infect
highest
among
young
individu
infect
less
common
person
older
year
perhap
secondari
preexist
immun
antigen
similar
virus
sever
differ
season
pandem
influenza
respons
monitor
spread
influenza
worldwid
declar
pandem
coordin
global
respons
howev
local
health
care
system
need
develop
surveil
detect
monitor
pandem
strain
import
emerg
physician
cogniz
patient
present
sever
ili
epidemiolog
link
southeast
asia
particular
china
diagnosi
within
first
hour
hospit
may
repres
patient
emerg
respiratori
infect
patient
sever
respiratori
infect
fever
new
onset
cough
short
breath
radiograph
evid
acut
respiratori
distress
syndrom
lifethreaten
complic
enceph
emerg
physician
enquir
patient
travel
histori
close
contact
person
travel
especi
southeast
asia
contact
health
care
provid
patient
requir
isol
consult
infect
control
team
pandem
comprehens
screen
process
need
triag
limit
exposur
patient
health
care
worker
elabor
pandem
beyond
scope
articl
